Corient Private Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9M Buy
262,371
+104,730
+66% +$29M 0.08% 222
2026
Q1
$46.4M Buy
157,641
+4,586
+3% +$1.36M 0.07% 249
2025
Q4
$41.8M Buy
153,055
+25,468
+20% +$6.92M 0.06% 273
2025
Q3
$32.3M Buy
127,587
+34,474
+37% +$9.38M 0.05% 302
2025
Q2
$25.7M Sell
93,113
-4,405
-5% -$1.2M 0.03% 347
2025
Q1
$25.9M Buy
97,518
+3,950
+4% +$974K 0.04% 346
2024
Q4
$21.7M Buy
93,568
+845
+0.9% +$194K 0.04% 379
2024
Q3
$20.5M Sell
92,723
-6,216
-6% -$1.29M 0.03% 416
2024
Q2
$19.5M Sell
98,939
-5,407
-5% -$1.12M 0.03% 389
2024
Q1
$22.5M Sell
104,346
-1,080
-1% -$227K 0.04% 361
2023
Q4
$22.2M Buy
105,426
+17,115
+19% +$3.65M 0.04% 369
2023
Q3
$17.7M Sell
88,311
-6,588
-7% -$1.31M 0.04% 374
2023
Q2
$17.6M Buy
94,899
+9,210
+11% +$1.7M 0.04% 371
2023
Q1
$16.4M Buy
85,689
+5,959
+7% +$1.08M 0.04% 351
2022
Q4
$13.4M Buy
+79,730
New +$13.9M 0.05% 322

Other funds holding CME

Corient Private Wealth's CME Position: Q2 2026 in Review

Corient Private Wealth increased its CME Group (CME) stake by 66% in Q2 2026, buying an estimated $29M and bringing the position to 262,371 shares worth $57.9M. The position accounts for 0.08% of the portfolio, ranked #222.

Corient Private Wealth first reported a position in CME in Q4 2022 and has held it in 15 quarters since. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Corient Private Wealth held 262,371 shares of CME Group worth $57.9M as of Q2 2026.
  • Corient Private Wealth bought 104,730 CME Group shares in Q2 2026, an estimated $29M.
  • CME Group made up 0.08% of Corient Private Wealth's portfolio in Q2 2026, its #222 holding.
  • Corient Private Wealth first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • 1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.